8.00BMarket Cap
19.77P/E TTM
Qiagen NV's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Qiagen NV is 9.58, ranking 20 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 19.77, which is 549.92% below the recent high of 128.51 and 12.34% above the recent low of 17.33.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.